ENDEAVOR SPRINT RX CORONARY STENT SYSTEM
Report
- Report Number
- 2953200-2010-02496
- Event Type
- Injury
- Date Received
- December 9, 2010
- Date of Event
- September 20, 2010
- Report Date
- November 11, 2010
- Manufacturer
- MEDTRONIC CARDIOVASCULAR GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P060033
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GA, US
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4): EVAL RESULTS: MYOCARDIAL INFARCTION.
THE PT UNDERWENT THE INDEX PROCEDURE WITH DEPLOYMENT OF ONE ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG ELUTING STENT TO THE THIRD OBTUSE MARGINAL. POST STENT DEPLOYMENT RESIDUAL STENOSIS WAS 0% WITH TIMI III FLOW. THE PT RECEIVED A PERI-PROCEDURAL LOADING DOSE OF STUDY MEDICATION CLOPIDOGREL, 300 MG AND ALSO BEGAN ASPIRIN 325 MG DOSING. THE FOLLOWING DAY THE PT BEGAN 75 MG CLOPIDOGREL DOSING. THE PT WAS DISCHARGED FROM THE INDEX PROCEDURE HOSPITALIZATION. DURING A 6 MONTHS FOLLOW CALL, THE PT REPORTED BEING HOSPITALIZED AT AN OUTLYING HOSPITAL. APPROXIMATELY 5.5 MONTHS POST INDEX PROCEDURE, THE PT WAS ADMITTED WITH CHEST PAIN AND A NON ST ELEVATION MI. THE CARDIAC ENZYMES WERE REPORTED AS POSITIVE. THE PT WAS FOUND TO BE POSITIVE FOR COCAINE USE. NO CARDIAC CATHETERIZATION WAS PERFORMED. THE DIAGNOSIS OF A POSSIBLE SUBENDOCARDIAL MYOCARDIAL INFARCT WAS MADE. THIS EVENT WAS REPORTED DUE TO BEING A SERIOUS EVENT REQUIRING PT HOSPITALIZATION. IN THE OPINION OF THE INVESTIGATOR, THE NON ST ELEVATION MI WAS SEVERE IN INTENSITY, NOT RELATED TO THE STUDY DRUG, NOT RELATED TO THE STUDY DEVICE, AND NOT RELATED TO THE STUDY PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDEAVOR SPRINT RX CORONARY STENT SYSTEM | NIQ | MEDTRONIC CARDIOVASCULAR GALWAY | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 61 YR | Hospitalization |